Ngā hua rapu - Claxton, D F

  • E whakaatu ana i te 1 - 2 hua o te 2
Whakamahine hua
  1. 1
    The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties.

    The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties. mā Zent, C S, Mathieu, C, Claxton, D F, Zhang, D E, Tenen, D G, Rowley, J D, Nucifora, G

    I whakaputaina 1996
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation

    PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation mā Kong, Y, Zhang, J, Claxton, D F, Ehmann, W C, Rybka, W B, Zhu, L, Zeng, H, Schell, T D, Zheng, H

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: